Opaleye Management Inc. bought $2.9M of Sol-Gel Technologies (SLGL)
Executed Mar 24, disclosed Mar 24, the same day.
Over the 21 trading sessions from the disclosed entry session (Mar 24), the stock returned -1.5% (delay-adjusted); from the execution session (Mar 24), -1.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Opaleye Management Inc. (10% owner) filed 36 Form 4 reports as a reporting entity in the trailing twelve months (22 purchases, 14 sales, 3 filed past the two-business-day deadline), most often in CDXS. Across 18 priced purchase filings, the average 21-session return was +19.2% from execution and +19.4% from disclosure (delay-adjusted; derived). The largest single filing was $7.8M of HROW (197,263 sh across 3 lots, as filed), executed Mar 3.
Healthcare · Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,631 sh × $66.80
Exec Sep 10
Filed Sep 14 · 5:23 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $591K
8,587 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 7:18 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $2.8M
40,113 sh across 4 lots
Exec Aug 28
Filed Aug 31 · 6:24 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $101K
1,400 sh × $71.97
Exec Jul 2
Filed Jul 2 · 6:11 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $101K
1,563 sh × $64.43
Exec May 20
Filed May 22 · 4:05 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $232K
3,437 sh across 2 lots
Exec May 12
Filed May 14 · 4:05 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $123K
2,173 sh × $56.57
Exec Jan 22
Filed Jan 23 · 5:42 PM ET SLGLPURCHASE Sol-Gel Technologies Ltd. $100K
2,394 sh × $41.92
Exec Jan 2
Filed Jan 6 · 4:05 PM ET